| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 29,766 | 28,548 | 26,873 | 37,773 | | Cost of Revenue | 17,833 | 18,495 | 16,296 | 22,426 | | | Gross Profit | 11,933 | 10,053 | 10,577 | 15,347 | | | Operating Expenses | | Research Development | 2,488 | 3,097 | 2,824 | 3,027 | | Selling General and Administrative | 10,797 | 15,399 | 14,974 | 18,280 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,352) | (8,443) | (7,221) | (5,960) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | (186) | (18) | 341 | | Earnings Before Interest And Taxes | (1,360) | (8,629) | (7,239) | (5,619) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,360) | (8,629) | (7,239) | (5,619) | | Income Tax Expense | (465) | (2,564) | (3,230) | (2,967) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (895) | (6,065) | (4,009) | (2,652) | | | Non-recurring Events | | Discontinued Operations | 430 | (18,881) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (465) | (24,946) | (4,009) | (2,652) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($465) | ($24,946) | ($4,009) | ($2,652) |
|
2.27% Nasdaq 0.00%
Income Statement
